THE fact that poisoning by guanidine is accompanied by a hypoglycmmia suggested to Frank, of Breslau, that it might be worth while to search among guanidine derivatives for a substance which could act as a substitute-for insulin.
To have any practical value for this purpose the substance would obviously need to have a more potent action in lowering the blood-sugar, in proportion to its general toxic action, than guanidine itself possessed. The first derivative to be tried was, not unnaturally, agmatine, the base produced by decarboxylating the normally occurring diamino-acid arginine. Agmatine, or guanidyl-butylamine NH2 I, CH-NH-CH.2-CH.2-CH2-CH2-NH2 NH2 Agmatine was found to have some power of lowering the blood-sugar and a smaller toxicity than guanidine itself. The relation became more favourable as the carbon chain was lengthened, and ultimately a compound was obtained which appeared to Frank, Nothmann and Wagner to be sufficiently promising to warrant an extended clinical trial; and to this the name "syntbalin" was given by its manufacturers. The formula was not divulged for some time, but it was ultimately made known that synthalin consisted of a long, straight, aliphatic chain of ten links, with a guanidine group attached to each end, so that it could be chemicallv described as decamethylenediguanidine. NH2 NH2 N CH NH.CH2.(CH2)8.CH2-NH-CH NH2 NH2 NH2.
Synthalin. The synthalin issued for therapeutic use was apparently the dihydrochloride of this base, made into tablets with some binding material. According to the experiments of Frank and his colleagues, synthalin lowered the blood-sugar of the dog made diabetic by operation, reducing it to or below the normal level. In the normal F-TH3bkP 1 Dale: Discu8sion on the Action of Synthalin animal it could produce a pronounced hypoglycaemia, with characteristic convulsions, relieved by the injection of glucose. In this cardinal feature, therefore, its action, at least superficially, resembled that of insulin. It differed, however, in important details. The action of insulin begins almost immediately, whereas that of synthalin usually begins to be manifest only after a delay of some hours. On the other hand, synthalin had the practical advantage that its action could be produced with administration by the mouth; it is only by this method, indeed, that it has been tried in practical medicine.
A substance promising such convenience of administration, as compared with the tiresome injections required by the insulin treatment, was sure of a ready trial. It may be taken as a general rule, to which of course there may be exceptions, that a new remedy which is going to establish itself as a permanent and valuable addition to therapeutic methods finds a substantial unanimity of approval fairly early in its career. There may be difficulties and complications attending its use in the early stages, but the advantages soon become so obvious that much ingenuity is directed to eliminating the drawbacks, so that general acceptance is not long delayed. In recent medical history we may take salvarsan and insulin as examples. There is another class of remedies in which the history takes a different course. Enthusiasm engendered by a limited number of early and optimistic reports soon shows a tendency to decline, as the opportunity of trial spreads to a wider constituency. Experience seems to find new limitations and drawbacks to their usefulness rather than better methods of applying them. In course of time such remedies are superseded, and retain only a historical interest as stages on the way to something better; or, if they find a more permanent use, it is in a more restricted field than first impressions had suggested. To this latter class I am inclined to think that synthalin belongs. I may not interpret the signs correctly, and those who follow me are far better able than I to judge the probability of its permanent value.
From my point of view, as an experimental physiologist, the interest of synthalin has lain in a different direction. Whether it should achieve a permanent place in therapeutics, or fall into gradual disuse, a substance having an action so suggestively similar to that of insulin in some of its features, could not fail to have interest, as possibly giving a clue to some part of the unknown structure of insulin itself. From this point of view, the matter of chief importance was to discover whether the hypoglyctumia, which synthalin could certainly produce, was the result of an action fundamentally similar to that of insulin, and differing from it chiefly in its intensity and its time relations; or whether, on the other hand, the resemblance was only superficial, the hypoglycasmia being produced by an action of a fundamentally different type. In the latter event, whatever the practical value of synthalin in symptomatic treatment, it could throw but little light on the central problem of the nature of insulin.
Accordingly the workers in my laboratory, in particular my colleague, Mr. Marks, and Dr. Richard Bodo, a visiting Hungarian pharmacologist, have carried out a number of experiments during the past year on the details of the action of synthalin, in comparison with those already known to us of the action of insulin. They repeated, in the first instance, the observations on its effects when administered to normal rabbits, and studied in detail the course of the reaction. Very large doses, in comparison with those used in therapeutics, had to be given to produce any definite effect at all. Even then the result was somewhat uncertain. The effect during the first hour or two was usually a rise in the blood-sugar percentage. Later it usually began to fall fairly rapidly, and after from four to six hours, according to the dose administered, a definite hypoglycemia had appeared which, unless relieved, produced the characteristic convulsions. The extent of the initial rise of the blood-sugar varied much, probably in accordance with the original glycogen load of the rabbit's liver. Two points were of great significance. The first was that, if the animal was killed when hypoglycaemia had appeared, and the liver was analysed, it was found to have lost practically all its glycogen, only minimal traces being detectable. A similar observation has recently been published by Staub. A second point was that when this hypoglycomia had been produced, no relief of it, or even a lasting restoration of a normal or high blood-sugar, would save the life of the animal. In other words, the dose necessary to produce hypoglycaemia in the rabbit was a generally toxic dose and its effects were not, as in the case of insulin, limited to a specific effect on the blood-sugar. The third and highly significant point was that, even before a definite hypoglycewmia had set in, adrenalitn, in doses which would normally produce a large and prolonged rise of blood-sugar, failed to have any such effect.
The impression produced on us by these observations was that while synthalin in sufficiently high doses would certainly produce a great, though delayed, fall of the blood-sugar, these doses had to be large enough to produce a serious impairment of the function of the liver. It lost all its glycogen, and since the blood-sugar fell at the same time, it seemed probable that its normal power of forming carbohydate from other substances was severely depressed. Further, it either lost the power of responding to adrenalin by accelerated conversion of its glycogen into glucose, or its glycogen was so early exhausted that adrenalin had no scope for such action;
The one feature of the action, as thus displayed, which could be regarded as having a true and fundamental resemblance to that of insulin, and not merely a superficial one, was the depression of new carbohydrate formation, which the experiments of Laufber&er, and more recently those of my colleagues and myself, have shown to be one of the two main effects of insulin. Whereas in the case of insulin, however, such an effect, if we are correct in postulating its occurrence, is a temporary and physiological one, in the case of synthalin we had no evidence to warrant us in assuming that it was other than a more permanent and tox'ic impairment of liver function.
In favour of such a view is the observation recorded by Staub, that the livers of rabbits thus treated with synthalin show definite signs of degenerative changes. We might consider, furt,her, as indications in the same direction, the clinically recorded fact that the synthalin treatment may be unsuitable and even dangerous to patients whose livers are already unhealthy; and perhaps, also, the fact that the means most widely advocated for counteracting the anorexia and nausea which the synthalin treatment is liable to produce, especially in certain patients, is the simultaneous administration of the salt of a bile acid-sodium dehydrocholeic acid, commercially known as " decholin."
The fact that synthalin, in doses sufficiently large to produce a definite fall of blood-sugar in the normal rabbit, appeared thus permanently to injure the cells of the liver, could not of course be taken to exclude the possibility that smaller, therapeutic doses, administered to a patient who could tolerate the treatment, might produce a depression of the new formation of glucose in the liver by a milder degree of this action, involving no permanent impairment. Such an action would not be easy to differentiate from one aspect of the action of insulin. It would then remain for further experiment to decide whether this action on the liver represented the whole of the action of synthalin, as seen either in its therapeutic application, or in laboratory.,experiments with large doses; or whether, on the other hand, synthalin also reproduced to any degree the other and at least equally important side of the action of insulin, in which it facilitates the removal from the circulating blood of carbohydrate already present as glucose, by causing it to be taken up by thetissues, especially the muscle, and there deposited in the form of glycogen.
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The next series of experiments by Bodo and Marks were directed to the decision of this question. The observations were not easy. When the percentage of glucose in the blood of the artificially perfused organ, or of the eviscerated spinal preparation, is kept at a relatively steady level by infusion of glucose at a constant rate, the addition of insulin causes an acceleration so immediate, so large, and so abrupt, in the rate at which glucose disappears from the blood, that the effect is easily detected. In the case of synthalin, however, the effect even of large doses is at best weak, delayed and gradual in onset, and liable to be obscured by toxic effects on the heart and the blood-vessels, rendering the circulation imperfect, so that much greater precautions are required to exclude other causes of change before any result can be accepted as significant. The results obtained by my colleagues, when all the necessary precautions had been taken, seem to me, as to them, to point definitely to the production by large doses of synthalin of an increase in the rate at which glucose disappears from the blood circulating through the voluntary muscles. So far its effect in this direction also, though differing in its intensity and its time relations, appears to resemble that of insulin. A closer scrutiny, however, directed to discovery of the extra sugar thus disappearing under synthalin, has failed to substantiate this appearance of similarity. The proportion of glycogen in the muscles, which exhibits such a pronounced increase under the action of insulin and remains so remarkably steady under the conditions of these experiments when no insulin is given, has always shown a significant decline when synthalin is given in doses' adequate definitely to increase the rate at which glucose leaves the blood. So far from the change in the muscle glycogen accounting for the glucose lost, it merely provides an additional loss also needing explanation. The second most obvious possibility was that the glucose had been oxidized. Here again, however, oxygen consumption by the preparation falls, under the action of synthalin, to as little as one-half of its previous rate. Before we conclude that synthalin really causes glucose to disappear into some "unknown complex," the possibility has still to be examined that it may be neither synthetized nor oxidized, but simply cloven to lactic acid. A pronounced rise in the respiratory quotient has already been' observed by Bodo and Marks, such as would be compatible with such a fate of the glucose, and arrangements are now being made for putting this possibility directly to the test in the immediate future.
As regards this action on preformed glucose we have, therefore, again an indication of an effect having a resemblance to that of insulin, but falling short of identity when examined in detail. In this case again, however, the possibility is not excluded that the proportionately smaller doses, which are effective on the diabetic patient, may have an effect more closely similar to that of insulin. If lactic acid is, indeed, the substance immediately produced from the disappearing glucose, it may in turn be built up into glycogen, and the lack of this final stage of the synthesis, under the conditions of the laboratory experiment, may be due to the necessity of employing doses so large, in order to demonstrate the effect with certainty in a limited time, that a secondary toxic action on the tissues and the cardiovascular mechanism cuts short the transformation at the intermediate stage.
In favour of such a view may be mentioned the fact that Arndt, Miiller and Schemann, in a quite recent paper, state that synthalin, in doses too small to affect the blood-sugar definitely, causes-glycogen to appear in the liver of the fasting rabbit.
Looking at the experimental data in this manner, one would, expect tQ find that synthalin had a limited power of ameliorating the symptoms of the diabetic condition, but that the margin between the therapeutic and the toxic dose would be a relatively narrow one, and that in some patients the two would overlap. Its low solubility in water might be ekpected to make its action slow and cumulative. At best we should expect it to act as a partial substitute for insulin in a proportion of cases, and in others to be relatively useless and badly tolerated. The prophetic form which I have given to this statement is, of course, a mere rhetorical device. The expectation thus set forth has been realized in the clinical records, if I have rightly read them, in advance of the experimental data. I am merely concerned to show that the practical result is compatible with those of the experimental analysis, so far as this has proceeded. DR. GEORGE GRAHAM.
Dr. Dale has described the experiments which have been made on animals in order to discover the action of synthalin, and has shown that it does not act in the same way as insulin. The reports about its value in clinical medicine have varied greatly. The original paper by Frank, Nothmann and Wagner [1], showed that it produced good effects, both as to the sugar and as to the ketosis, but had no effects in cases of coma; tbe early workers in Germany all reported good results. Jansen and Baur [2], however, working in Munich, obtained poor results, and showed.'that the respiratory quotient was not raised. In America Joslin [31 has had some success, and thinks that synthalin may be useful in some cases. Rabinowitch [4] , in Montreal, agrees with this opinion. In this country the reports have differed greatly. Lawrence [5] had no success, but Leyton [5] and McLean [5] both had some success.
My task this evening is, therefore, to consider whether synthalin has any action on the glycnmia and glycosuria ofpatients, whether it produces any evil effects, and whether it has any place in therapeutics. We have not used it in many cases, because we did not feel justified in trying it on patients who were doing very well with insulin, as this would have interfered with their work. The great majority do not want to make any change until we can say definitely that synthalin will help them.
All the patients were in hospital and were kept in bed while the observations were being made. The diet was kept constant, and the sisters and nurses were accustomed to look after diabetic patients.
Ca8e I.-The first patient tested was a young man whose disease had begun only four weeks before admission. The disease was fairly mild as, on a diet of carbohydrate 120 grm., protein 81 grm., and fat 130 grn., only 40 to 50 grm. of sugar were excreted, and the blood-sugar was always above 250 mgm..
The treatment was begun with insulin, and when it had been increased to 20 + 20 units, the glycosuria was reduced to only 6 grm., though the blood-sugar at 10 a.m. was still 220 mgm. The insulin was then omitted for two-days, and the glycosuria increased to 24 grm. Synthalin was then given in the manner prescribed by Professor Frank: 20 + 20 mgin. for three days, and then a day's rest before starting the next course of three days. The glycosuria decreased to 6 grm. on the third day, and on the " rest " day only a faint trace of sugar could be detected and there was none for nine hours of the day. In the next period, 25 + 25 mgm. were given for two days, and then 25 mgm. once. During this course the glycosuria was not so well controlled, as 10 grm. a day were excreted, but on the day of the third course it was reduced to a mere trace for three days. The synthalin was then omitted for tbree days, and the sugar output rose to 45 grm., but was decreased to a faint trace after three days of synthalin. As the patient was getting anxious to return to work, the observations were stopped; the carbohydrate was restricted and control easily maintained with a normal blood-sugar on a diet of 50 grm. carbohydrate with 18 + 18 units of insulin. Although the urine sugar was much decreased, the blood-sugar at 10 a.m. did not fall below 180 mgm. The effect of the insulin as compared with synthalin and " no drug " was shown very clearly. The usual effect of insulin was obtained. With synthalin the blood-sugar was 220 mgm. at 10 a.m., and, in spite of meals, fell to 170 mgm. at 3.30 p.m. Three days later after no therapy, the blood-sugar at 10 a.m. was 260 mgm., and, as the effect of the meals, had risen to 360 mgm. at 12.30 p.m., and was still at 260 mgm. at 3.30 p.m. I have to thank Dr. Harrison for the blood-sugar estimations in this case.
Ca8e II.-A second patient who had a very mild diabetes was excreting 10 grm. sugar on a diet of 100 grm. carbohydrate, and the blood-sugar was usually about 200 mgm. After two courses of synthalin no sugar was excreted in the urine. .The next day a sugar tolerance test with 50 grm. dextrose was performed and compared with the previous one. Although the curve was still abnormal, it showed a considerable improvement on the previous curve, and no sugar was excreted, whereas 6 4 grm. had previously been excreted.
The observations on these two patients convinced us that synthalin had a definite action on the sugar of the blood and urine. We realized, however, that the way in which it had been used in the first case gave, little chance of attaining the ideal of a normal blood-sugar and no glycosuria.
In the next series of patients we restored the blood-sugar to normal with the necessary amount of insulin, and then attempted to substitute some of the insulin by synthalin.
Case 11I.-A man, aged 53. The blood-sugar was reduced to normal on a diet of 35 grm. of carbohydrate by means of 25 + 25 units of insulin. The synthalin, 25 + 25 mgm. in three-day courses, was then given. Many blood-sugar determinations were made and the insulin was gradually reduced to 10 + 8 units, a saving of 30 units, and the blood-sugar remained normal. The carbohydrate has been incr4ased to 55 grm., and he has now taken synthalin for six months with no ill effects. In November the synthalin was omitted for seven days, and the blood-sugar was normal on the third day, but had risen to 220 mgm. on the seventh day, and seven days later, after two courses of synthalin, it had fallen to 80 mgm. The man feels well, and has gained 14 lb. in weight. Although 30 units of insulin have been replaced by synthalin, it has not been possible to dispense with an injection of insulin.
Ca8e IV.-A woman, who on a diet of 32 grm. carbohydrate required 15 unit3 of insulin, and the blood-sugar in the day varied from 100 to 200 mgm. In this case it has been possible to dispense with the insulin altogether, and she has had synthalin for the last six months. The blood-sugar varies from 100 to 170 mgm. at 10.30 a.m. She feels well, but the weight has not increased.
The results in these two patients are fair, but the subsequent ones are not so satisfactory. The toxic manifestations of synthalin are a very serious drawback, although they do not often amount to more than nausea and vomiting with an associated anorexia. Jaundice has been reported by Adler in two cases, one of which ended fatally. Adler [6] has introduced the use of decholin, which has enabled him to increase the dose of synthalin to 70 mgm. a day without causing any symptoms. We did not have any available for this patient, and since then the toxic symptoms have usually arisen after the patient has left hospital, and we have not yet tried its action.
Ca8e VI.-A boy, aged 16, who required 15 + 15 units of insulin to keep the blood-sugar normal on a diet containing 47 grm. carbohydrate. 25 mgm. synthalin were given, and the evening dose was gradually reduced. As the blood-sugar remained normal, the morning dose of 15 units was gradually decreased. He went out of hospital with a normal blood-sugar, but immediately developed nausea. After a two days' pause the synthalin was given for only two days at a time. He continued well with a normal blood-sugar until the twentieth course, when the blood-sugar, at 10.30 aim., was 200 mgm. After the thirtieth course he developed severe nausea and vomiting. The synthalin was replaced by 15 + 12 units of insulin, and this has been increased to 20 + 20 units. The blood-sugar is still not lower than 200 mgm.
During the ten weeks of the synthalin treatment he gained 2 lb., and in the next five weeks with insulin no less than 10 lb. Although the blood-sugar is not yet controlled, he looks much better and says that he does not want to have synthalin again.
Case VII.-A woman, aged 60, who required 10 + 5 units of insulin on a diet of 41 grm. carbohydrate. Both doses of insulin were replaced by 25 mgm. synthalin. The blood-sugar remained normal, and she felt well until the thirtieth course, when she developed a severe urticaria. The blood-sugar was over 200 mgm. on this day. I do not think urticaria has been described so far, but as it was possible that it was caused by the synthalin, the drug was stopped. She now needs 10 + 5 units of insulin, and the blood-sugar is not quite stable yet.
Case VIII.-A woman of 19, who is rather unreliable and has had many septic illnesses. Her insulin requirements have risen from 10 units in 1923 to 100 units. She was admitted because of a small abscess following an injection. The daily range of blood-sugar was normal with 50 + 45 + 5 units of insulin on a diet of carbohydrate 20 grm., protein 65 grm, and fat 100 grm. After three courses of synthalin, the insulin was reduced to 30 + 25 + 5 units. The course was complicated by the healing of the abscess, but a saving of 40 units of insulin wag effected. On another admission she required 40 + 25 + 5 units on a diet of 35 grm. carbohydrate. With synthalin the dose was decreased to 25 + 15 + 5, a saving of 25 units. After three weeks she developed nausea and vomiting, and tle synthalin was stopped. Dr. Linder was away and the insulin was not increased, and shd was very nearly in coma three days later.
Thus, in these four cases, although synthalin saved some insulin, it had to be abandoned on account of toxic symptoms.
In the next four cases it was almost a complete failure, and I will only refer to one.
A small girl, whose blood-sugar was most difficult to control, varied from hyperglycsemia to hypoglycemia very easily. On a diet of 30 grm. carbohydrate she excreted 12 grm. sugar in spite of 20 + 10 units of insulin, and the blood-sugar at 10 a.m. was 330 mgm. Synthalin 10 + 10 mgm. was given for two days, and the insulin reduced to 10 + 10 units, and on the second day altered to 12 + 4 units. The sugar excreted was rather lower at 6 grm., and on the next day, when no synthalin was given, rose again to 17 grm. in spite of 8 + 10 + 4 units. 15 + 15 mgm. synthalin were then given, and no insulin. On this day she excreted 38 grm. sugar, and the next morning had severe nausea and vomiting. She looked very ill and had the deep abdominal breathing of incipient coma. Rothera's test for aceto-acetic acid was very strongly positive. With insulin and sugar she recovered in the course of the day. On a subsequent occasion synthalin was tried again, but had no effect.
Thus, in eight out of twelve cases there was a definite effect with synthalin, but in only two cases has the drug been continued for more than four months. In four there were acute symptoms; in two it was abandoned for other reasons; and in four it was a failure.
These results are better than some which have been reported by other workers, but are nothing like so good as those originally reported by Frank.
The three questions I set myself to answer were:
(1) Has synthalin any action on the glycemia and glycosuria? To this we must answer "yes," but add that it works unevenly, sometimes causing a good result and sometimes 'none at all. It differs from insulin which, if given in a sufficient dose, only fails on very rare occasions. Graham-Lawrence: Discussion on the, Action of Synthatin
(2) Has it any evil effects? Again, the answer is "yes," as it causes toxic symptoms and there is no way of telling which patient is liable to have such symptoms.
(3) Has it any place in the treatment of diabetes mellitus? This is a much more difficult question, and I will answer it in this way: for those patients who need insulin and are willing to have it synthalin has no value at present. To those who are unwilling to have more than one dose of insulin, although they really should haye two doses, synthalin may belp. To those who, mistakenly, as I think, will do anything to avoid insulin although they need it, synthalin may help and is worthy of a trial. It is at least better than any other mouth preparation, as it certainly has some definite action which the others have not. Under these circumstances I am prepared to recommend its trial, but only if the patient can be properly watched, and if the synthalin is stopped as soon as any toxic symptoms arise.
In conclusion, I think that synthalin is a definite step in advance, and it is to be hoped that other preparations may be discovered which are free from its toxic properties.
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My initial experience with synthalin from January to April of this year (1927) was as discouraging as could well be. In two mild cases of diabetes, synthalin had its usual effect in reducing the glycosuria and the blood-sugars to a slight extent. The glycosuria was reduced by 10 grm. in one case and by 30 grm. in the other, but the reduction in the second case was mostly produced by digestive disturbance, and the administration of synthalin had to be abandoned. With four severe and moderately severe cases I tried to substitute synthalin partially and entirely for moderate doses of insulin, but failed to produce any definite results. (I thought 15 units was spared in one case, but when the synthalin was withdrawn the reduced dose of insulin had the same effect. This case developed pain and tenderness over the liver, which subsided when the synthalin was discontinued.) I showed these results to Prof. Frank, who had no criticisms to offer of my method of using synthalin, and admitted that these were common enough results in cases who were really dependent on insulin. He could only advise further trial. He told me that synthalin could seldom be continued indefinitely, but Had to be remitted every six to eight weeks, so it seemed to me that the study was hardly worth pursuing any further. My next experience with synthalin, or at least guanidine compounds, has taken place quite unwittingly in connexion with glukhorment. Dr. Dale asked me to investigate the action of this new antidiabetic remedy introduced by Professor von Noorden, and the clinical results I have obtained in two cases support his chemical analysis that glukhorment is probably nothing but synthalin or a synthalin-like substance associated with a pancreatic digest. The first case shows the usual effect in that the glycosuria was reduced by some 10 grm. in a mild diabetic, and the second shows the best results I have so far obtained with guanidine compounds. The case was severe, a girl of ten, who could tolerate three tablets of glukhorment or 10 mgm. of synthalin without digestive upset (see Table) . This undoubtedly spared about 10 to 15 units of insulin. Glukhorment produced a slight and transient albuminuria, and the toxic symptoms produced by glukhorment and synthalin were exactly similar. Neither drug had any effect on her weight or general clinical condition.
To sum up my small but careful experience with synthalin, I should say that it presents many more disadvantages than advantages in the treatment of diabetes. The disadvantages are:-
(1) Its frequent toxic action when given in efficacious doses and the probability that its action is always due to a mildly toxic effect.
(2) The uncertainty of its action and the fact that it cannot spare much insulin in severe cases.
(3) The fact that it cannot be taken continuously in effective doses, but must be remitted on account of its depressing effect, and at these times the insulin and diet must be readjusted, an impracticable procedure.
(4) The fact that it does not increase weight and strength like insulin, and that it acts as a toxic inhibitor of catabolism rather than as a promoter of normal anabolism, like insulin.
It might be of some value for patients who refuse insulin altogether, or who will submit to only one injection daily, and for cases who will not diet properly; the latter might be benefited by the reduction of appetite that synthalin produces! I do not think that synthalin has brought anything of practical importance into the routine treatment of diabetes, which still depends on diet and insulin, if necessary. Indeed, by introducing a third factor, of doubtful value, I fear it can only do harm in general use. Dr. P. J. CAMMIDGE said that the results of experiments with synthalin upon animals which he and Mr. Howard had carried out agreed, in the main, with those described by Dr. Dale, although they had employed therapeutic doses of 1 5 to 2mgm. per kilo. In fasting rabbits the maximum effect of such doses was not seen until from twenty to twentytwo hours had elapsed, and it had been found that the fali in the blood-sugar was more pronounced, and occurred later, in animals with naturally low fasting bloodsugar than in those in which it was initially high. In Mr. Howard's and his experience, white rats had proved to be more susceptible to the effects of synthalin than rabbits. These animals had been employed in an investigation of its effects upon the respiratory quotient. Therapeutic doses had been found to have no immediate effect, but after an interval of from twenty to twenty-four hours there was a distinct rise of from 5 to 10 per cent., although there was no increase of oxygen consumption. Clinically, the most striking feature of synthalin therapy had been the much more satisfactory results obtained in elderly people, in whom the glycosuria. was commonly of the anapothectic or defective storage type, than in young people iXi whom achriatic glycosuria, with defective utilization of sugar, was the general rule.
